About Peptideworth

Peptideworth answers one question about a peptide: what does the published evidence actually show? Not what a seller says, not what a forum has decided, and not what a mechanism implies it ought to do. For each compound we go after the specifics that determine whether a finding means anything — the trial phase, how many people were in it, for how long, against which endpoint, who paid for it, and what has never been tested at all.

Start with the goal. Follow the evidence. That is the shape of the site: you arrive with a goal, and the guide tells you how far the evidence for each option really goes before it tells you anything else.

We cover what people are searching for, including compounds with no approval and no human data. That is a deliberate choice. Those searches are happening either way, and the pages currently answering them are largely written by the people selling the vial. An accurate account of a thin literature is a better outcome than a sales page dressed as research.

The rule that keeps that defensible: coverage is never a recommendation, and pages about unapproved compounds carry no affiliate link and name no vendor. If a page’s conclusion is that no human trial exists, there is nothing on it for you to buy.

Every claim is tied to a primary source — the trial record, the registry entry, the label, the regulator’s database — and citations are resolved live rather than written from memory. Claims about what does not exist are dated and bounded, so you get “as of this month, none of these trials has posted results” rather than a vague universal that quietly decays. Every compound page carries a mandatory “catch”: the uncomfortable part, in plain language.

The full method, including how citations are re-verified and why our calculators output arithmetic and never a dose, is in the editorial policy.

Grant reads the trial literature behind every peptide Peptideworth covers, and says plainly when the evidence is thin — most of it is animal data, and the guides say so. Grant Delaney is Peptideworth’s Research Editor.

The competence claimed here is narrow and deliberate: reading the literature and reporting it accurately. This site has no medical credential, no medical review board, no named clinical reviewer, and no peer review. If a qualified clinical reviewer is ever contracted, they will be named on the pages they reviewed. We would rather understate what we are than borrow authority we have not earned.

Worth being blunt about, since much of this niche blurs the line:

• we are not a clinic, and reading this creates no clinical relationship;
• we are not a pharmacy or a compounder, and we sell, ship, and supply nothing;
• we run no laboratory and test no product for purity or identity;
• we prescribe nothing and recommend no dose to anyone.

The publisher of this site is the site: peptideworth.com. There is no company name or corporate address to give you, and inventing one for the look of it is not something a site built on sourcing claims gets to do. The full statement is in the medical disclaimer.

Reader-funded through affiliate commission on some outbound links, at no extra cost to you. Commission never determines which compounds are covered or how favorably the evidence is characterized, and no company previews or approves anything before it is published. There are no display ads and no sponsored posts. The complete account is on the disclosure page.

One address for everything: research@peptideworth.com. The message we most want is the one that says a figure on this site does not match the paper it cites — a misread sample size or a trial phase we got wrong is worth more to us than praise, and our corrections policy describes exactly what we do when one arrives.